ClinicalTrials.Veeva

Menu

Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions (ETOLE)

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

BRCA2 Protein
Tomosynthesis
Breast Neoplasms
BRCA1 Protein

Treatments

Device: Standard mammography
Device: Standard mammography and tomosynthesis

Study type

Interventional

Funder types

Other

Identifiers

NCT02959398
P120121

Details and patient eligibility

About

Tomosynthesis is an innovative technique developed in digital mammography for obtaining a sectional image of the breast. Mammography has the main disadvantage of being an imaging projection that creates overlays, which eliminates tomosynthesis.

The objective of this study is to evaluate if the BI-RADS classification obtained by tomosynthesis with synthetic mammography is superior to that obtained by conventional mammography in terms of specificity while not inferior in terms of sensitivity.

Enrollment

2,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient having clinical or breast imaging abnormalities classified as BiRads 3, 4, 5 (Table 1). (5)
  • Patient over 18 years old
  • Signed informed consent

Exclusion criteria

  • Patients at high risk of breast cancer, mutations BRCA 1 (BReast CAncer gene 1) or BRCA 2 (BReast CAncer gene 2) carriers, Li Fraumeni, or history of thoracic radiation will be excluded because of their greater sensitivity to ionizing radiation.
  • Patient unable to give informed consent for physical, mental, or legal reasons.
  • Patient not affiliated with French Social Security Insurance.
  • Patient under treatment for breast cancer.
  • When mammography is not recommended according to good practice by the French Health Authority (HAS).
  • Pregnant patient.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

standard mammography
Active Comparator group
Description:
standard mammography
Treatment:
Device: Standard mammography
standard mammography and tomosynthesis
Experimental group
Description:
standard mammography and tomosynthesis
Treatment:
Device: Standard mammography and tomosynthesis

Trial contacts and locations

2

Loading...

Central trial contact

cedric De Bazelaire, MD PHD; Matthieu Resche-Rigon, MD PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems